Literature DB >> 23274576

Acidic urine is associated with poor prognosis in patients with chronic heart failure.

Yoichiro Otaki1, Tetsu Watanabe, Hiroki Takahashi, Hiromasa Hasegawa, Shintaro Honda, Akira Funayama, Shunsuke Netsu, Mitsunori Ishino, Takanori Arimoto, Tetsuro Shishido, Takehiko Miyashita, Takuya Miyamoto, Tsuneo Konta, Isao Kubota.   

Abstract

Renal dysfunction is reported to be associated with poor outcomes in patients with chronic heart failure (CHF). A recent study showed that acidic urine is related to chronic kidney disease, which is a risk factor for the development of CHF. However, it remains to be determined whether acidic urine is associated with poor outcomes in patients with CHF. We measured urine pH using dipsticks in 537 patients with CHF. Acidic urine was defined as urine pH ≤5.5. Patients were prospectively followed during a median follow-up period of 556 days. There were 145 cardiac events. Prevalence of acidic urine was increased with advancing stage of chronic kidney disease. Patients with acidic urine had a more severe New York Heart Association functional class compared with those with normal urine. In the multivariate Cox proportional hazard analysis, acidic urine was independently associated with poor outcomes in patients with CHF after adjustment of confounding factors. A Kaplan-Meier analysis demonstrated that the rate of cardiac events was higher in patients with acidic urine than in those with normal urine. The presence of acidic urine can reliably identify patients at high risk of future cardiac events in patients with CHF.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23274576     DOI: 10.1007/s00380-012-0312-z

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  36 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Contribution of urinary titratable acid to acid-base homeostasis.

Authors:  R M Culpepper; A C Schoolwerth
Journal:  Am J Kidney Dis       Date:  1992-02       Impact factor: 8.860

Review 3.  Role of NH3 and NH4+ transporters in renal acid-base transport.

Authors:  I David Weiner; Jill W Verlander
Journal:  Am J Physiol Renal Physiol       Date:  2010-11-03

Review 4.  Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment.

Authors:  Jeffrey A Kraut; Ira Kurtz
Journal:  Am J Kidney Dis       Date:  2005-06       Impact factor: 8.860

5.  Angiotensin II-forming pathways in normal and failing human hearts.

Authors:  H Urata; B Healy; R W Stewart; F M Bumpus; A Husain
Journal:  Circ Res       Date:  1990-04       Impact factor: 17.367

Review 6.  Acute decompensated heart failure and the cardiorenal syndrome.

Authors:  Kelly V Liang; Amy W Williams; Eddie L Greene; Margaret M Redfield
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

7.  Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study.

Authors:  Kazuhide Ogino; Masahiko Kato; Yoshiyuki Furuse; Yoshiharu Kinugasa; Katsunori Ishida; Shuichi Osaki; Toru Kinugawa; Osamu Igawa; Ichiro Hisatome; Chiaki Shigemasa; Stefan D Anker; Wolfram Doehner
Journal:  Circ Heart Fail       Date:  2009-11-20       Impact factor: 8.790

8.  Adaptive change in ammonia excretion in renal insufficiency.

Authors:  A J MacClean; J P Hayslett
Journal:  Kidney Int       Date:  1980-05       Impact factor: 10.612

9.  Angiotensin II stimulates vesicular H+-ATPase in rat proximal tubular cells.

Authors:  C A Wagner; G Giebisch; F Lang; J P Geibel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

10.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

View more
  7 in total

1.  Acetazolamide as a potent chloride-regaining diuretic: short- and long-term effects, and its pharmacologic role under the 'chloride theory' for heart failure pathophysiology.

Authors:  Hajime Kataoka
Journal:  Heart Vessels       Date:  2019-05-21       Impact factor: 2.037

2.  Increased cystatin C levels as a risk factor of cardiovascular events in patients with preserved estimated glomerular filtration rate after elective percutaneous coronary intervention with drug-eluting stents.

Authors:  Eiryu Sai; Kazunori Shimada; Katsumi Miyauchi; Yoshiyuki Masaki; Takahiko Kojima; Tadashi Miyazaki; Takeshi Kurata; Manabu Ogita; Shuta Tsuboi; Takuma Yoshihara; Tetsuro Miyazaki; Akimichi Ohsaka; Hiroyuki Daida
Journal:  Heart Vessels       Date:  2015-04-12       Impact factor: 2.037

3.  Additive clinical value of serum brain-derived neurotrophic factor for prediction of chronic heart failure outcome.

Authors:  Shinpei Kadowaki; Tetsuro Shishido; Yuki Honda; Taro Narumi; Yoichiro Otaki; Daisuke Kinoshita; Satoshi Nishiyama; Hiroki Takahashi; Takanori Arimoto; Takuya Miyamoto; Tetsu Watanabe; Isao Kubota
Journal:  Heart Vessels       Date:  2015-01-24       Impact factor: 2.037

4.  Exercise and Interorgan Communication: Short-Term Exercise Training Blunts Differences in Consecutive Daily Urine 1H-NMR Metabolomic Signatures between Physically Active and Inactive Individuals.

Authors:  Leon Deutsch; Alexandros Sotiridis; Boštjan Murovec; Janez Plavec; Igor Mekjavic; Tadej Debevec; Blaž Stres
Journal:  Metabolites       Date:  2022-05-24

5.  Serum cholinesterase is an important prognostic factor in chronic heart failure.

Authors:  Takamasa Sato; Hiroyuki Yamauchi; Satoshi Suzuki; Akiomi Yoshihisa; Takayoshi Yamaki; Koichi Sugimoto; Hiroyuki Kunii; Kazuhiko Nakazato; Hitoshi Suzuki; Shu-ichi Saitoh; Yasuchika Takeishi
Journal:  Heart Vessels       Date:  2014-01-25       Impact factor: 2.037

6.  Low urine pH associated with sarcopenia in the elderly: A multi-center observational study.

Authors:  Akihiro Saitsu; Yoshitaka Iwazu; Haruka Matsushita; Hirotaka Hayashi; Yumiko Mizuhashi; Kazuhiko Kotani
Journal:  Medicine (Baltimore)       Date:  2021-05-28       Impact factor: 1.817

7.  Response to "Acetazolamide and Cardiac Failure".

Authors:  Tomasz Imiela; Andrzej Budaj
Journal:  Clin Drug Investig       Date:  2018-07       Impact factor: 2.859

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.